Changing health behaviors to improve health outcomes after angioplasty: A randomized trial of net present value versus future value risk communication

Health Education Research

Volumn 23, Issue 5, 2008, Pages 826-839

  Charlson, M E ^a   Peterson, J C ^a   Boutin Foster, C ^a   Briggs, W M ^b   Ogedegbe, G G ^c   McCulloch, C E ^d   Hollenberg, J ^a   Wong, C ^a   Allegrante, J P ^a,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CENTRAL MICHIGAN UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Weill Cornell Medical College New York ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ANGIOPLASTY; ARTICLE; BEHAVIOR CHANGE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEALTH BEHAVIOR; HEALTH STATUS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STENT; STROKE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BEHAVIOR THERAPY; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; POSTOPERATIVE CARE; RISK ASSESSMENT; RISK REDUCTION BEHAVIOR;

EID: 52449131810     PISSN: 02681153     EISSN: 14653648     Source Type: Journal    
DOI: 10.1093/her/cym068     Document Type: Article

References (43)

1. Cavender JB, Rogers WJ, Fisher LD et al. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 1992; 20: 287-94.
2. Galan KM, Deligonul U, Kern MJ et al. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty. Am J Cardiol 1988; 61: 260-3.
3. Myler RK, Shaw RE, Stertzer SH et al. Recurrence after coronary angioplasty. Cathet Cardiovasc Diagn 1987; 13: 77-86.
4. Ramanathan KB, Vander Zwaag R, Maddock V et al. Interactive effects of age and other risk factors on long-term survival after coronary artery surgery. J Am Coll Cardiol 1990; 15: 1493-9.
5. Reis GJ, Kuntz RE, Silverman DI et al. Effects of serum lipid levels on restenosis after coronary angioplasty. Am J Cardiol 1991; 68: 1431-5.
6. Watts GF, Lewis B, Brunt JN et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet 1992; 339: 563-9.
7. Brown G, Albers JJ, Fisher LD et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in mean with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-98.
8. McKenna KT, Mass F, McEniery PT. Coronary risk factor status after percutaneous transluminal coronary angioplasty. Heart Lung 1995; 24: 207-12.
9. Gaw BL. Motivation to change life-style following PTCA. Dimens Crit Care Nurs 1992; 11: 68-74.
10. Gulanick M, Bliley A, Perino B et al. Recovery patterns and lifestyle changes after coronary angioplasty: the patient's perspective. Heart Lung 1998; 27: 253-62.
11. Allegrante JP, Roizen MF. Can net-present value economic theory be used to explain and change health-related behaviors? Health Educ Res 1988; 13: i-iv.
12. Charlson ME, Allegrante JP, McKinley PS et al. Improving health behaviors and outcomes after angioplasty: using economic theory to inform intervention. Health Educ Res 2002; 17: 606-18.
13. Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. Applications to addictive behaviors. Am Psychol 1992; 47: 1102-14.
14. Prochaska J, Redding C, Evers K. The transtheorectical model and states of change. Health Behavior and Health Education. New York, NY: Jossey Bass, 1997
15. Bandura A. Social Learning Theory. Englewood Cliffs, NJ: Prentice-Hall, 1977
16. Strecher V, DeVellis B, Becker M et al. The role of self-efficacy in achieving health behavior change. Health Educ Q 1986; 13: 73-91.
17. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
18. Rimm EB, Giovannucci EL, Stampfer MJ et al. Reproducibility and validity of an expended self-administered semi-quantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992; 135: 1114-26 discussion 1127-36.
19. Liu S, Stampfer M, Hu F et al. Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr 1999; 70: 412-9.
20. Liu S, Lee I, Ajani U et al. Intake of vegetables rich in carotenoids and risk of coronary heart disease in men: the Physicians' Health Study. Int Epidemiol Assoc 2001; 30: 130-5.
21. Sesso H, Liu S, Gaziano J et al. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 2003; 133: 2336-41.
22. Taylor HL, Jacobs DR, Schucker B et al. A questionnaire for the assessment of leisure time physical activities. J Chronic Dis 1997; 31: 741-55.
23. Ni Mhurchu C, Margetts B, Speller V. Applying the stages-of-change model to dietary change. Nutr Rev 1997; 55: 10-6.
24. Jeffery R, French S, Rothman A. Stage of change as a predictor of success in weight control in adult women. Health Psychol 1999; 18: 543-6.
25. Costakis C, Dunnagan T, Haynes G. The relationship between the stages of exercise adoption and other health behaviors. Am J Health Promot 1999; 14: 22-30.
26. Boyle R, O'Connor P, Pronk N et al. Stages of change for physical activity, diet, and smoking among HMO members with chronic conditions. Am J Health Promot 1998; 12: 170-5.
27. Nigg C, Burbank P, Padula C et al. Stages of change across ten health risk behaviors for older adults. Gerontologist 1999; 39: 473-82.
28. Emmons KM, Rollnick S. Motivational interviewing in health care setting. Opportunities and limitations. Am J Prev Med 2001; 20: 68-74.
29. Ornish D, Brown SE, Scherwitz LW et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-33.
30. Haskell WL, Alderman EL, Fair JM et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 1994; 89: 975-90.
31. Ornish D, Scherwitz L, Billings J et al. Intensive lifestyle changes for reversal of coronary heart disease. J Am Med Assoc 1998; 280: 2001-7.
32. Koertge J, Weidner G, Elliott-Eller M et al. Improvement in medical risk factors and quality of life in woman and men with coronary artery disease in the Multicenter Lifestyle Demonstration Project. Am J Cardiol 2003; 91: 1316-22.
33. Pasquali S, Alexander K, Coombs L et al. Effect of cardiac rehabilitation on functional outcomes after coronary revascularization. Am Heart J 2003; 145: 445-51.
34. Group VHS. Influence on lifestyle measures and five-year coronary risk by a comprehensive lifestyle intervention programme in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 2003; 10: 429-37.
35. Group, E.I.a.I. European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROSPIREI and II in nine countries. Lancet 2001; 357: 995-1001.
36. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. J Am Med Assoc 2002; 288: 2868-79.
37. Champion V, Foster J, Menon U. Tailoring interventions for health behavior change in breast cancer screening. Cancer Pract 1997; 5: 283-8.
38. Prochaska J, DiClemente C, Velicer W et al. Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 1993; 12: 399-405.
39. Alasewski A, Horlick-Jones T. How can doctors communicate information about risk more effectively? Br Med J 2003; 327: 729-31.
40. Alasewski A. A person-centered approach to communicating risk. PLoS Med 2005; 2: e41.
41. Skolbekken J. Communicating the risk reduction achieved by cholesterol reducing drugs. Br Med J 1998; 316: 1956-8.
42. Sheeran P. Intention-behavior Relations. A Conceptual and Empirical Review. Chichester, England, 2002, 1-36.
43. Michie S, Abraham C. Interventions to change health behaviors: evidence based or evidence-inspired? Psychol Health 2004; 19: 29-49.